Search by product name, CAS, target or catalog number. Press Down Arrow to reach product suggestions, Tab to move between links, and Escape to close suggestions.
Glucosidase inhibitors block enzymes that cleave glucose units from oligosaccharides, disaccharides and glycoproteins. Intestinal α-glucosidases break down dietary carbohydrates, so their inhibitors are used to study postprandial glucose uptake. Acarbose, a pseudo-oligosaccharide, and miglitol, an iminosugar, are standard inhibitors of these enzymes. In the endoplasmic reticulum, glucosidases I and II trim glucose residues from newly attached N-linked glycans. Trimming and later reglucosylation control glycoprotein binding to the chaperone calnexin, as reported in 1995. Deoxynojirimycin and celgosivir inhibit these processing glucosidases and are used in glycoprotein folding and virology research. Miglustat hydrochloride, an N-alkylated iminosugar, also inhibits glucosylceramide synthase in glycosphingolipid research.
Cyclophellitol aziridine is a cyclophenol analogue that acts as a potent inhibitor of β-glucosidase. This compound demonstrates significant potential in studying carbohydrate metabolism and related enzymatic pathways. Its inhibitory activity makes it a valuable tool for investigating β-glucosidase-related diseases and for screening potential therapeutic agents.
Valiolamine is an aminocyclitol that functions as an alpha-glucosidase inhibitor. It exhibits significant inhibitory activity against porcine intestinal sucrase and maltase, with Ki values of 30 nM and 350 nM, respectively. This compound is valuable for research applications focused on carbohydrate metabolism, specifically in studying the modulation of glucose absorption and the potential therapeutic approaches to disorders such as diabetes.
Panasenoside is a flavonoid that acts as an α-glucosidase inhibitor. Derived from Lilium pumilum DC, it has demonstrated significant inhibitory activity against α-glucosidase, making it a valuable tool for research on carbohydrate metabolism and related disorders. This compound is relevant for studies investigating diabetes management and the modulation of postprandial blood glucose levels.
β-Hydroxypropiovanillone is an α-glucosidase inhibitor that demonstrates significant concentration-dependent inhibitory effects on this enzyme. With an IC50 value of 257.8 μg/mL, it is useful for studying carbohydrate metabolism and potential therapeutic applications in managing postprandial hyperglycemia. This compound may serve as a valuable research tool in the exploration of diabetes and related metabolic disorders.
Magnoloside B is an α-glucosidase inhibitor with an IC50 value of 0.69 mM, derived from the stem bark of Magnolia officinalis. It exhibits moderate inhibitory activity against MGC-803 and HepG2 cancer cell lines. This compound is of significant interest for research applications related to cancer and diabetes.
Synonyms: Kaempferol 3,7-diglucoside
Kaempferol-3,7-di-O-β-glucoside is a flavonol that acts as an inhibitor of α-amylase, α-glucosidase, and acetylcholinesterase. This compound has demonstrated protective effects on differentiating neuronal cells, specifically SH-SY5Y, against injury induced by Amyloid β peptide. Its enzyme inhibitory properties and neuroprotective effects indicate potential applications in Alzheimer's disease research and therapeutics.
(+)-Afzelechin is an alpha-glucosidase inhibitor derived from the rhizomes of Bergenia ligulata. It demonstrates an ID50 value of 0.13 mM, indicating its potency in inhibiting alpha-glucosidase activity. This compound effectively delays carbohydrate absorption, thereby reducing postprandial hyperglycemia and hyperinsulinemia. It serves as a valuable tool for research in metabolic disorders and glycemic control.
Synonyms: Ganodermadiol
Ganoderol B is a potent inhibitor of α-glucosidase, exhibiting significant enzymatic inhibition with an IC50 value of 48.5 μg/mL (119.8 μM). This compound is primarily utilized in research applications related to carbohydrate metabolism and glucose regulation, making it a valuable tool in studies of diabetes and postprandial hyperglycemia. Researchers may leverage Ganoderol B to explore mechanisms of glycemic control and to develop therapeutic strategies targeting α-glucosidase.
Synonyms: (-)-Pinoresinol 4-O-β-D-glucopyranoside
(-)-Pinoresinol 4-O-glucoside serves as a potent α-glucosidase inhibitor, exhibiting an IC50 value of 48.13 µM. This compound promotes cell migration and early differentiation of pre-osteoblasts while enhancing the protein levels of BMP2, phosphorylated Smad1/5/8, and RUNX2. Additionally, it demonstrates protective effects against oxidative stress, hyperglycemia, and hepatic toxicity. (-)-Pinoresinol 4-O-glucoside is a valuable reagent for investigating osteoporosis and periodontal disease.
α-Glucosidase-IN-11 is a potent competitive inhibitor of α-glucosidase, exhibiting an IC50 value of 0.56 μM. This compound selectively binds to tryptophan residues in the enzyme, influencing its protein folding and activity. α-Glucosidase-IN-11 has potential applications in the regulation of carbohydrate metabolism and blood glucose control, making it a valuable tool for diabetes research and therapeutic development.
Synonyms: MOR 14; N-Methyl-1-deoxynojirimycin; N-Methylmoranolin
N-Methylmoranoline is a potent α-glucosidase inhibitor that modulates carbohydrate metabolism by interfering with enzyme activity. This compound demonstrates significant potential in research related to diabetes management and metabolic disorders by reducing glucose absorption. It is utilized in studies exploring glycemic control and the pharmacological effects of glycosidase inhibition.
Glucocerebrosidase-IN-1 hydrochloride is a potent and selective inhibitor of glucocerebrosidase (GCase), demonstrating an IC50 of 29.3 μM and a Ki of 18.5 μM. This compound is relevant for research applications concerning Gaucher disease and Parkinson's disease, as it influences cellular metabolism of glucocerebrosides. Its selective inhibition makes it a valuable tool for studying the biochemical pathways associated with these conditions.
Carpachromene is a potent inhibitor of the α-glucosidase enzyme. It has been shown to ameliorate insulin resistance in HepG2 cells by modulating the IR/IRS1/PI3K/Akt/GSK3/FoxO1 signaling pathway. This compound is valuable for researching metabolic disorders and potential therapeutic strategies for diabetes management.
(S)-N-(1H-Indole-3-acetyl)tryptophan is a tryptophan derivative that serves as a weak inhibitor of β-D-glucosidase. Its biological activity may be leveraged in research focused on enzymatic pathways and metabolic processes where β-D-glucosidase plays a significant role. This compound can be utilized in various biochemical studies exploring the interactions and regulation of tryptophan derivatives in cellular contexts.
Casuarictin is a potent α-glucosidase inhibitor, exhibiting competitive inhibition with an IC50 of 0.21 μg/mL. It also acts as an inhibitor of presenilin stabilization factor-like protein (PSFL). This compound is valuable for research applications related to Alzheimer's disease and metabolic disorders, providing insights into therapeutic strategies targeting carbohydrate metabolism.
Synonyms: (1R,2S,3S,4S,6R)-4-Amino-6-(hydroxymethyl)cyclohexane-1,2,3-triol
Validamine is a competitive inhibitor of β-glucosidase, demonstrating pH-dependent and dose-dependent inhibition with an IC50 value of 2.92 mM. Its maximum inhibitory effect occurs at the enzyme's optimal pH, making it a valuable tool for studying β-glucosidase function and regulation. This compound can be utilized in research applications focused on carbohydrate metabolism and related pathways.
Out of stock
All 3 sizes
Diphlorethohydroxycarmalol is a phlorotannin that serves as an inhibitor of α-glucosidase and α-amylase, exhibiting IC50 values of 0.16 mM and 0.53 mM, respectively. This compound demonstrates significant anti-diabetic activity, making it relevant for research focused on glucose metabolism and diabetes management. Its mechanism of action highlights its potential application in developing therapeutic strategies for metabolic disorders.
p-Hydroxyphenethyl trans-ferulate is an α-glucosidase inhibitor known for its anti-hyperglycemic properties, exhibiting an IC50 value of 19.24 ± 1.73 µM against yeast α-glucosidase. This compound also demonstrates antioxidant and anti-inflammatory activities, making it a valuable tool in the study of metabolic disorders. Additionally, p-Hydroxyphenethyl trans-ferulate has shown potential in inhibiting cancer cell proliferation and modulating serotonergic activity, supporting its application in cancer and neurological research.
EB-0156 is a potent inhibitor of endoplasmic reticulum α-glucosidases I and II, exhibiting IC50 values of 0.0479 μM and less than 0.001 μM, respectively. Derived from valiolamine, this compound demonstrates broad-spectrum antiviral activity. EB-0156 is valuable for research focused on developing therapeutic agents against both existing and emerging viral pathogens.
Out of stock
All 3 sizes
Synonyms: DG(16:1/0:0/16:1); 1,3-Dipalmitolein
1,3-Dipalmitoleoyl glycerol is an α-glucosidase inhibitor with significant biological activity derived from sea cucumber viscera. This compound demonstrates varying degrees of inhibitory effects on α-glucosidase from diverse sources, making it valuable for research into carbohydrate metabolism and related disorders. Its application in studying glycosidase functions can provide insights into metabolic pathways and potential therapeutic targets.
α-Glucosidase-IN-6 is a competitive inhibitor of α-glucosidase, exhibiting an IC50 of 5.69 µM. This compound demonstrates potential anti-diabetic activity by modulating carbohydrate metabolism. It is applicable in research focused on diabetes treatment and metabolic disorders.
Flaccidoside III is a triterpenoid compound that functions as an α-glucosidase inhibitor, exhibiting an IC50 value of 256.7 μM. It demonstrates significant potential for antioxidant and antidiabetic activities, making it a valuable reagent in metabolic research and studies aimed at understanding glucose regulation. Its effects on α-glucosidase modulation contribute to its implications in diabetes management research.
3-Oxo-hop-22(29)-ene is a potent inhibitor of α-glucosidase, predominantly affecting yeast enzymes. This compound exhibits moderate inhibitory effects on the viability of Trichomonas cruzi and Leishmania mexicana, suggesting its potential as a therapeutic agent against these pathogens. Additionally, 3-Oxo-hop-22(29)-ene displays marginal anti-inflammatory activity, highlighting its multifaceted biological applications in research.
α-Glucosidase-IN-4 is a reversible, mixed-type inhibitor of α-glucosidase, exhibiting an IC50 value of 12.98 μM. This compound serves as a valuable tool for studying carbohydrate metabolism and its associated disorders, including diabetes and obesity. Its ability to modulate α-glucosidase activity makes it suitable for research into therapeutic strategies targeting glycemic control.
α-Glucosidase-IN-12 is a potent inhibitor of α-glucosidase, exhibiting an IC50 value of 10.20 μM. This compound effectively modulates carbohydrate digestion and absorption, making it valuable for research on metabolic disorders such as type 2 diabetes and obesity. Its use in biochemical assays provides insights into enzymatic activity and potential therapeutic strategies.
Out of stock
All 3 sizes